Trial Profile
Retrospective study on antidiabetic effects of linagliptin in patient groups of normal renal function and mild or severe renal impairment
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Dec 2015
Price :
$35
*
At a glance
- Drugs Linagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics; Therapeutic Use
- 06 Dec 2015 New trial record